Michael Abecassis, M.D.

Northwestern University Feinberg School of ...Chicago, Illinois - 60611 (312-695-4549) Northwestern University, Northwestern Memorial HospitalChicago, Illinois - 60611-3013 Northwestern Memorial HospitalChicago, Illinois - 60611 (312-695-3270) Northwestern UniversityChicago, Illinois - 60611 |
- CLINICAL TRIALS 4
- CONDITIONS6
- INTERVENTIONS10
- SINCE2005

Study of Glycemic Control on Liver Transplantation Outcomes
April 2009 - June 2011

Radiofrequency Ablation Chemoembolization and/or Radioembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
August 2009 - August 2018

HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H
July 2007 - July 2011

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
October 2005 - October 2015
Hepatitis
Hepatitis C
Hepatitis C, Chronic
Liver Neoplasms
Carcinoma, Hepatocellular
Hyperglycemia
Cisplatin
Doxorubicin Hydrochloride
Insulin
Mitomycin C
Radiofrequency Ablation
Yttrium Y 90 Glass Microspheres
Infusion Of Donor Hematopoietic Stem Cells And Campath-1h
Continuous Maintenance Immunosuppressive Therapy
Immunosuppression Withdrawal
Liver Transplant



